WebFeb 8, 2024 · Insider Monkey Transcripts. Carlisle Companies Incorporated (NYSE: CSL) Q4 2024 Earnings Call Transcript February 7, 2024. Operator: Good afternoon. My … WebFeb 5, 2024 · Carlisle Companies Inc (CSL 2.97%) Q4 2024 Earnings Call Feb 4, 2024, 5:00 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator.
Carlisle Cos Inc (CSL) Q1 2024 Earnings Call Transcript
WebHalf Year. Filter by Year: 2024 2024 2024 2024 2024. 14-Feb-2024. CSL Half Year Results Announcement & Investor Presentation. 14-Feb-2024. CSL Statutory Accounts for the … pomelo foundation
Financials CSL Limited
WebFeb 10, 2024 · Trades from $ 1. Carlisle (. CSL Quick Quote. CSL - Free Report) came out with quarterly earnings of $2.92 per share, beating the Zacks Consensus Estimate of $2.62 per share. This compares to ... WebCSL's 2024 Half Year Financial Results - Announcement Information. We have announced our 2024 Half Year Results for the period ending 31st December 2024. Announcement Information and Webcast Recording were released on Tuesday, 14th February 2024 … CSL's 2024 Half Year Financial Results - Announcement Information We have … CSL's latest and archived ASX Announcements We focus on rare and … Clinical trials cannot be done without the people who choose to participate. Some … CSL's clinical trials are one of the most important steps in the years-long … CSL has had innovation in its DNA since 1916, and it continues to be at the core … CSL is a global leader in developing and delivering high quality medicines that … CSL Seqirus is the world’s No. 2 influenza vaccine provider in sales with operations … WebApr 6, 2024 · As of April 6, 2024, the average one-year price target for Carlisle Companies is $335.75. The forecasts range from a low of $303.00 to a high of $367.50. The average price target represents an ... pomelo health create account